1,561
Views
21
CrossRef citations to date
0
Altmetric
Review

Nutrition-based interventions for mood disorders

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 303-315 | Received 10 Dec 2020, Accepted 22 Jan 2021, Published online: 03 Mar 2021

References

  • Rakofsky J, Rapaport M Mood disorders. Continuum (minneap minn). 2018 Jun;24(3, BEHAVIORAL NEUROLOGY AND PSYCHIATRY):804–827.
  • Jorm AF, Patten SB, Brugha TS, et al. Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries. World Psychiatry. 2017 Feb;16(1):90–99.
  • Souery D, Papakostas GI, Trivedi MH. Treatment-resistant depression. J Clin Psychiatry. 2006;67(Suppl 6):16–22.
  • Colpo GD, Leboyer M, Dantzer R, et al. Immune-based strategies for mood disorders: facts and challenges. Expert Rev Neurother. 2018 Feb;18(2):139–152.
  • Lassale C, Batty GD, Baghdadli A, et al. Healthy dietary indices and risk of depressive outcomes: a systematic review and meta-analysis of observational studies. Mol Psychiatry. 2019 Jul;24(7):965–986.
  • Marx W, Moseley G, Berk M, et al. Nutritional psychiatry: the present state of the evidence. Proc Nutr Soc. 2017 Nov;76(4):427–436.
  • Adan RAH, van der Beek EM, Buitelaar JK, et al. Nutritional psychiatry: towards improving mental health by what you eat. Eur Neuropsychopharmacol. 2019 Dec; 29 (12):1321–1332.
  • Sarris J, Logan AC, Akbaraly TN, et al. Nutritional medicine as mainstream in psychiatry. Lancet Psychiatry. 2015 Mar;2(3):271–274.
  • Marx W, Lane M, Hockey M, et al. Diet and depression: exploring the biological mechanisms of action. Mol Psychiatry. 2021 Jan; 26(1):134–150.
  • Fries GR, Walss-Bass C, Bauer ME, et al. Revisiting inflammation in bipolar disorder. Pharmacol Biochem Behav. 2019 Feb;177:12–19.
  • Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009 Feb;71(2):171–186.
  • Strawbridge R, Arnone D, Danese A, et al. Inflammation and clinical response to treatment in depression: a meta-analysis. European Neuropsychopharmacology. 2015 Oct;25(10):1532–1543. .
  • Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010 Mar 1;67(5):446–457.
  • Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013 Sep ;12(11):200.
  • Strine TW, Mokdad AH, Balluz LS, et al. Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. Psychiatr Serv. 2008 Dec;59(12):1383–1390.
  • Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010 Mar;67(3):220–229.
  • Tully A, Smyth S, Conway Y, et al. Interventions for the management of obesity in people with bipolar disorder. Cochrane Database Syst Rev. 2020 Jul ;20(7):CD013006.
  • Gonzalez-Muniesa P, Martinez-Gonzalez MA, Hu FB, et al. Obesity. Nat Rev Dis Primers. 2017 Jun ;15(3):17034.
  • Soto-Angona O, Anmella G, Valdes-Florido MJ, et al. Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches. BMC Med. 2020 Oct 1;18(1):261.
  • Guillemot-Legris O, Muccioli GG. Obesity-Induced Neuroinflammation: beyond the Hypothalamus. Trends Neurosci. 2017 Apr;40(4):237–253.
  • Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol. 2014 Feb;220(2):T1–T23.
  • Lyra ESNM, Lam MP, Soares CN, et al. Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes. Front Psychiatry. 2019;10:57.
  • Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001 Jun;24(6):1069–1078.
  • Stalder T, Steudte-Schmiedgen S, Alexander N, et al. Stress-related and basic determinants of hair cortisol in humans: a meta-analysis. Psychoneuroendocrinology. 2017;77:261–274.
  • Joseph JJ, Golden SH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci. 2017 Mar;1391(1):20–34.
  • Nandam LS, Brazel M, Zhou M, et al. Cortisol and major depressive disorder-translating findings from humans to animal models and back. Front Psychiatry. 2019;10:974.
  • Firth J, Siddiqi N, Koyanagi A, et al. The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry. 2019 Aug;6(8):675–712.
  • Castanon N, Luheshi G, Laye S. Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity. Front Neurosci. 2015;9:229.
  • Marx W, McGuinness AJ, Rocks T, et al. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies. Mol Psychiatry. 2020 Nov;23.
  • Raison CL, Dantzer R, Kelley KW, et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry. 2010 Apr;15(4):393–403.
  • Celik C, Erdem M, Cayci T, et al. The association between serum levels of neopterin and number of depressive episodes of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):372–375.
  • Kohler-Forsberg O, C Nl HC, et al. Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials. Acta Psychiatr Scand. 2019 May;139(5):404–419.
  • Phillips CM, Shivappa N, Hebert JR, et al. Dietary inflammatory index and mental health: a cross-sectional analysis of the relationship with depressive symptoms, anxiety and well-being in adults. Clin Nutr. 2018 Oct;37(5):1485–1491.
  • Cavicchia PP, Steck SE, Hurley TG, et al. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J Nutr. 2009 Dec;139(12):2365–2372.
  • Shivappa N, Steck SE, Hurley TG, et al. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014 Aug;17(8):1689–1696.
  • Allen J, Romay-Tallon R, Brymer KJ, et al. Mitochondria and Mood: mitochondrial Dysfunction as a Key Player in the Manifestation of Depression. Front Neurosci. 2018;12:386.
  • Bansal Y, Kuhad A. Mitochondrial dysfunction in depression. Curr Neuropharmacol. 2016;14(6):610–618.
  • Morris G, Walder K, McGee SL, et al. A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev. 2017 Mar;74(Pt A):1–20.
  • Black CN, Bot M, Scheffer PG, et al. Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology. 2015;51:164–175.
  • Andreazza AC, Kauer-Sant’anna M, Frey BN, et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord. 2008 Dec;111(2–3):135–144.
  • Palta P, Samuel LJ, Miller ER 3rd, et al. Depression and oxidative stress: results from a meta-analysis of observational studies. Psychosom Med. 2014 Jan;76(1):12–19.
  • Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020 Jul;21(7):363–383.
  • Sabuncuoglu S, Eken A, Aydin A, et al. Cofactor metals and antioxidant enzymes in cisplatin-treated rats: effect of antioxidant intervention. Drug Chem Toxicol. 2015 Oct;38(4):375–382.
  • Gardner A, Johansson A, Wibom R, et al. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Disord. 2003 Sep;76(1–3):55–68.
  • Campbell S, Marriott M, Nahmias C, et al. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry. 2004 Apr;161(4):598–607.
  • Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004 Nov;161(11):1957–1966.
  • Jacka FN, Cherbuin N, Anstey KJ, et al. Western diet is associated with a smaller hippocampus: a longitudinal investigation. BMC Med. 2015 Sep;8(13):215.
  • Teixeira AL, Colpo GD, Fries GR, et al. Biomarkers for bipolar disorder: current status and challenges ahead. Expert Rev Neurother. 2019 Jan;19(1):67–81.
  • Rowland T, Perry BI, Upthegrove R, et al. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses. Br J Psychiatry. 2018 Sep;213(3):514–525.
  • Bocchio-Chiavetto L, Bagnardi V, Zanardini R, et al. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry. 2010 Sep;11(6):763–773.
  • Moore A, Beidler J, Hong MY. Resveratrol and depression in animal models: a systematic review of the biological mechanisms. Molecules. 2018 Aug 30;23:9.
  • Zainuddin MS, Thuret S. Nutrition, adult hippocampal neurogenesis and mental health. Br Med Bull. 2012 Sep;103(1):89–114.
  • Cherif A, Roelands B, Meeusen R, et al. Effects of intermittent fasting, caloric restriction, and ramadan intermittent fasting on cognitive performance at rest and during exercise in adults. Sports Med. 2016 Jan;46(1):35–47.
  • Molteni R, Barnard RJ, Ying Z, et al. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience. 2002;112(4):803–814.
  • Stranahan AM, Norman ED, Lee K, et al. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus. 2008;18(11):1085–1088.
  • Park HR, Park M, Choi J, et al. A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor. Neurosci Lett. 2010 Oct 4;482(3):235–239.
  • Martin CR, Osadchiy V, Kalani A, et al. The Brain-Gut-Microbiome Axis. Cell Mol Gastroenterol Hepatol. 2018;6(2):133–148.
  • Pistollato F, Sumalla Cano S, Elio I, et al. Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr Rev. 2016 Oct;74(10):624–634.
  • Parker A, Fonseca S, Carding SR. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes. 2020;11(2):135–157.
  • Daulatzai J. Obesity and Gut’s Dysbiosis Promote Neuroinflammation, Cognitive Impairment, and Vulnerability to Alzheimer’s disease: New Directions and Therapeutic Implications. J Mol Genet Med. 2014;S1.
  • Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009 May;9(5):313–323.
  • Jiang H, Ling Z, Zhang Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–194.
  • Ley RE, Backhed F, Turnbaugh P, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11070–11075.
  • Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006 Dec 21;444(7122):1022–1023.
  • Rodrigues-Amorim D, Rivera-Baltanas T, Regueiro B, et al. The role of the gut microbiota in schizophrenia: current and future perspectives. World J Biol Psychiatry. 2018;21:1–15.
  • Jiang C, Li G, Huang P, et al. The Gut Microbiota and Alzheimer’s Disease. J Alzheimers Dis. 2017;58(1):1–15.
  • Terry N, Margolis KG. Serotonergic Mechanisms Regulating the GI Tract: experimental Evidence and Therapeutic Relevance. Handb Exp Pharmacol. 2017;239:319–342.
  • Zheng P, Zeng B, Zhou C, et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry. 2016 Jun;21(6):786–796.
  • Engevik MA, Luck B, Visuthranukul C, et al. Human-derived bifidobacterium dentium modulates the mammalian serotonergic system and gut-brain axis. Cell Mol Gastroenterol Hepatol. 2021; 11(1): 221-248.
  • Neufeld KM, Kang N, Bienenstock J, et al. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011 Mar;23(3):255–264. e119.
  • Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004 Jul 1;558(Pt 1):263–275.
  • de Miranda AS, Vieira ELM, Dos Reis Bastos J, et al. Role of gut microbiota in the GBR12909 model of mania-like behavior in mice. J Neuroimmunol. 2020 Jun ;16(346):577292.
  • Fasano A. Gut permeability, obesity, and metabolic disorders: who is the chicken and who is the egg? Am J Clin Nutr. 2017 Jan;105(1):3–4.
  • Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2365–2370.
  • Rieder R, Wisniewski PJ, Alderman BL, et al. Microbes and mental health: a review. Brain Behav Immun. 2017 ;66:9–17.
  • Huang TT, Lai JB, Du YL, et al. Current understanding of Gut Microbiota in Mood Disorders: an update of human studies. Front Genet. 2019;10:98.
  • Aslam H, Green J, Jacka FN, et al. Fermented foods, the gut and mental health: a mechanistic overview with implications for depression and anxiety. Nutr Neurosci. 2020 Sep;23(9):659–671.
  • Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):491–502.
  • Silveira ALM, Ferreira AVM, Teixeira MM High-fiber diets in Gastrointestinal Tract Diseases. Foods, Nutrients, and Dietary Supplements2019. p. 229–244.
  • Shin A, Preidis GA, Shulman R, et al. The Gut Microbiome in adult and pediatric functional gastrointestinal disorders. Clin Gastroenterol Hepatol. 2019 Jan;17(2):256–274.
  • Liu RT, Walsh RFL, Sheehan AE. Prebiotics and probiotics for depression and anxiety: a systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev. 2019 Jul;102:13–23.
  • Hill C, Guarner F, Reid G, et al. Expert consensus document The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 11 Aug 2014(8)506–514;
  • Ait-Belgnaoui A, Colom A, Braniste V, et al. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol Motil. 2014 Apr;26(4):510–520.
  • Janik R, Thomason LAM, Stanisz AM, et al. Magnetic resonance spectroscopy reveals oral Lactobacillus promotion of increases in brain GABA, N-acetyl aspartate and glutamate. Neuroimage. 2016 Jan;15(125):988–995.
  • Desbonnet L, Garrett L, Clarke G, et al. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008 Dec;43(2):164–174.
  • Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013 Nov 15; 74(10):720–726.
  • Amirani E, Milajerdi A, Mirzaei H, et al. The effects of probiotic supplementation on mental health, biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020;49:102361.
  • Huang R, Wang K, Hu J. Effect of Probiotics on Depression: a Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2016 Aug 6;8:8.
  • Goh KK, Liu YW, Kuo PH, et al. Effect of probiotics on depressive symptoms: a meta-analysis of human studies. Psychiatry Res. 2019 Dec;282:112568.
  • Ng QX, Peters C, Ho CYX, et al. A meta-analysis of the use of probiotics to alleviate depressive symptoms. J Affect Disord. 2018 Mar ;1(228):13–19.
  • Chinna Meyyappan A, Forth E, Wallace CJK, et al. Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review. BMC Psychiatry. 2020 Jun 15;20(1):299.
  • Green J, Castle D, Berk M, et al. Faecal microbiota transplants for depression - Who gives a crapsule? Aust N Z J Psychiatry. 2019 Aug;53(8):732–734.
  • Chinna Meyyappan A, The Safety MR. Efficacy, and tolerability of microbial ecosystem therapeutic-2 in people with major depression and/or generalized anxiety disorder: protocol for a Phase 1, open-label study. JMIR Res Protoc. 2020 Jun 4;9(6):e17223.
  • Sarris J, Schoendorfer N, Kavanagh DJ. Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments. Nutr Rev. 2009 Mar;67(3):125–131.
  • Sarris J, Murphy J, Mischoulon D, et al. Adjunctive Nutraceuticals for Depression: a Systematic Review and Meta-Analyses. Am J Psychiatry. 2016 Jun 1;173(6):575–587.
  • Ashton MM, Kavanagh BE, Marx W, et al. A systematic review of nutraceuticals for the treatment of bipolar disorder: une revue systematique des nutraceutiques pour le traitement du trouble bipolaire. Can J Psychiatry. 2020;23:706743720961734.
  • Guu TW, Mischoulon D, Sarris J, et al. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. Psychother Psychosom. 2019;88(5):263–273.
  • Sarris J, Byrne GJ, Stough C, et al. Nutraceuticals for major depressive disorder- more is not merrier: an 8-week double-blind, randomised, controlled trial. J Affect Disord. 2019 Feb 15;245:1007–1015.
  • Molendijk M, Molero P, Ortuno Sanchez-Pedreno F, et al. Diet quality and depression risk: a systematic review and dose-response meta-analysis of prospective studies. J Affect Disord. 2018 Jan;15(226):346–354.
  • Lai JS, Hiles S, Bisquera A, et al. A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults. The American Journal of Clinical Nutrition. 2014 Jan;99(1):181–197. .
  • Psaltopoulou T, Sergentanis TN, Panagiotakos DB, et al. Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol. 2013 Oct;74(4):580–591. .
  • Widmer RJ, Flammer AJ, Lerman LO, et al. The Mediterranean diet, its components, and cardiovascular disease. Am J Med. 2015 Mar;128(3):229–238. .
  • McLaren DS. The kingdom of the Keyses. Nutrition. 1997 Mar;13(3):249, 253.
  • Sanchez-Villegas A, Martinez-Gonzalez MA, Estruch R, et al. Mediterranean dietary pattern and depression: the PREDIMED randomized trial. BMC Med. 2013 Sep;11(1):208. .
  • Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013 Apr 4;368(14):1279–1290.
  • Ma J, Rosas LG, Lv N, et al. Effect of Integrated Behavioral Weight Loss Treatment and Problem-Solving Therapy on Body Mass Index and Depressive Symptoms Among Patients With Obesity and Depression: the RAINBOW Randomized Clinical Trial. JAMA. 2019 Mar 5;321(9):869–879.
  • Martinez-Lapiscina EH, Clavero P, Toledo E, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. Journal of Neurology, Neurosurgery & Psychiatry. 2013 Dec;84(12):1318–1325. .
  • Salari-Moghaddam A, Keshteli AH, Mousavi SM, et al. Adherence to the MIND diet and prevalence of psychological disorders in adults. Journal of Affective Disorders. 2019 Sep ;256(256):96–102. .
  • Morris MC, Tangney CC, Wang Y, et al. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimer’s & Dementia. 2015 Sep;11(9):1007–1014. .
  • Operto FF, Matricardi S, Pastorino GMG, et al. The ketogenic diet for the treatment of mood disorders in comorbidity with epilepsy in children and adolescents. frontiers in pharmacology. 2020;11:578396.
  • Brietzke E, Mansur RB, Subramaniapillai M, et al. Ketogenic diet as a metabolic therapy for mood disorders: evidence and developments. Neuroscience & Biobehavioral Reviews. 2018 Nov;94:11–16.
  • Paoli A, Rubini A, Volek JS, et al. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. European Journal of Clinical Nutrition. 2013 Aug;67(8):789–796. .
  • Broom GM, Shaw IC, Rucklidge JJ. The ketogenic diet as a potential treatment and prevention strategy for Alzheimer’s disease.. Nutrition (Burbank, Los Angeles County, Calif.). 2019 Apr;60:118–121.
  • Campbell IH, Campbell H. Ketosis and bipolar disorder: controlled analytic study of online reports. BJPsych Open. 2019 Jul 4;5(4):e58.
  • Phelps JR, Siemers SV, El-Mallakh RS. The ketogenic diet for type II bipolar disorder. Neurocase. 2013;19(5):423–426.
  • Neth BJ, Mintz A, Whitlow C, et al. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer’s disease: a pilot study. Neurobiology of Aging. 2020 Feb;86:54–63.
  • Jacka FN, O’Neil A, Opie R, et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Med. 2017 Jan 30;15(1):23. .
  • Parletta N, Zarnowiecki D, Cho J, et al. A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: a randomized controlled trial (HELFIMED). Nutritional Neuroscience. 2019 Jul;22(7):474–487. .
  • Jacka FN. Nutritional Psychiatry: where to Next? EBioMedicine. 2017 Mar;17:24–29.
  • Francis HM, Stevenson RJ, Chambers JR, et al. A brief diet intervention can reduce symptoms of depression in young adults – a randomised controlled trial. PLoS One. 2019;14(10):e0222768. .
  • Null G, Pennesi L. Diet and lifestyle intervention on chronic moderate to severe depression and anxiety and other chronic conditions. Complementary Therapies in Clinical Practice. 2017 Nov;29:189–193.
  • Teasdale SB, Samaras K, Wade T, et al. A review of the nutritional challenges experienced by people living with severe mental illness: a role for dietitians in addressing physical health gaps. Journal of Human Nutrition and Dietetics. 2017 Oct;30(5):545–553. .
  • Firth J, Marx W, Dash S, et al. The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials. Psychosomatic Medicine. 2019 Apr;81(3):265–280. .
  • Lane MM, Davis JA, Beattie S, et al. Ultraprocessed food and chronic noncommunicable diseases: a systematic review and meta-analysis of 43 observational studies. Obesity reviews. An Official Journal of the International Association for the Study of Obesity. 2020 Nov;9. DOI:10.1111/obr.13146
  • Sarris J, O’Neil A, Coulson CE, et al. Lifestyle medicine for depression. BMC Psychiatry. 2014 Apr;14(1):107. .
  • Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition. 2016 Mar;32(3):315–20.
  • Majeed M, Nagabhushanam K, Arumugam S, et al. Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study. Food & Nutrition Research. 2018;62:62.
  • Pinto-Sanchez MI, Hall GB, Ghajar K, et al. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology. 2017 Aug;153(2):448–459 e8.
  • Romijn AR, Rucklidge JJ, Kuijer RG, et al. A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression. Australian & New Zealand Journal of Psychiatry. 2017 Aug;51(8):810–821.
  • Dickerson F, Adamos M, Katsafanas E, et al. Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: a randomized controlled trial. Bipolar Disord. 2018 Nov;20(7):614–621.
  • Ghorbani Z, Nazari S, Etesam F, et al. The effect of synbiotic as an adjuvant therapy to fluoxetine in moderate depression: a randomized multicenter trial. Arch Neurosci. 2018;5:2
  • Kazemi A, Noorbala AA, Azam K, et al. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin Nutr. 2019 Apr;38(2):522–528.
  • Miyaoka T, Kanayama M, Wake R, et al. Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder: a prospective open-label trial. Clin Neuropharmacol. 2018 Sep/Oct;41(5):151–155.
  • Rudzki L, Ostrowska L, Pawlak D, et al. Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: a double-blind, randomized, placebo controlled study. Psychoneuroendocrinology. 2019;100:213–222.
  • Reininghaus EZ, Platzer M, Kohlhammer-Dohr A, et al. PROVIT: supplementary probiotic treatment and vitamin B7 in depression-a randomized controlled trial. Nutrients. 2020 Nov 8;12:11.
  • Eslami Shahrbabaki M, Sabouri S, Sabahi A, et al. The efficacy of probiotics for treatment of bipolar disorder-type 1: a randomized, double-blind, placebo controlled trial. Iran J Psychiatry. 2020 Jan;15(1):10–16.
  • Mocking RJ, Harmsen I, Assies J, et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry. 2016 Mar 15;6:e756.
  • Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006 Oct 18;296(15):1885–1899.
  • Wang J, Um P, Dickerman BA, et al. Zinc, Magnesium, Selenium and Depression: a Review of the Evidence, Potential Mechanisms and Implications. Nutrients. 2018 May 9;10:5.
  • Vellekkatt F, Menon V. Efficacy of vitamin D supplementation in major depression: a meta-analysis of randomized controlled trials. J Postgrad Med. 2019 Apr-Jun;65(2):74–80.
  • Jamilian H, Amirani E, Milajerdi A, et al. The effects of vitamin D supplementation on mental health, and biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: a systematic review and meta-analysis of randomized controlled trials. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Aug;30(94):109651.
  • Bender A, Hagan KE, Kingston N. The association of folate and depression: a meta-analysis. J Psychiatr Res. 2017 Dec;95:9–18.
  • Hsieh YC, Chou LS, Lin CH, et al. Serum folate levels in bipolar disorder: a systematic review and meta-analysis. BMC Psychiatry. 2019 Oct 22;19(1):305.
  • Galizia I, Oldani L, Macritchie K, et al. S-adenosyl methionine (SAMe) for depression in adults. Cochrane Database Syst Rev. 2016 Oct ;10(10):CD011286.
  • Kishi T, Miyake N, Okuya M, et al. N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials. Psychopharmacol (Berl). 2020 Nov;237(11):3481–3487.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.